USANA
October 22, 2025
SALT LAKE CITY, Utah -- October 22, 2025
USANA Health Sciences reported third-quarter results in line with preliminary figures it issued October 9, with net sales up 7 percent to 214 million dollars and a net loss of 6.5 million dollars, or 0.36 dollars per diluted share, compared with net earnings of 10.6 million dollars, or 0.56 dollars, a year earlier. Adjusted diluted earnings per share were a loss of 0.15 dollars and adjusted EBITDA fell to 13.8 million dollars from 24.6 million dollars. Sales included 31 million dollars from children's health brand Hiya, which ended the quarter with 193,400 active monthly subscribers.
Direct selling active customers fell to 388,000 from 452,000 as the company rolled out its enhanced Brand Partner compensation plan. Asia Pacific sales declined 13 percent to 140 million dollars, including a 9 percent drop in Greater China to 93 million dollars, while Americas and Europe sales rose 8 percent to 43 million dollars. USANA ended the quarter with 145 million dollars in cash and no debt.
Chief Executive Jim Brown said the company has begun a comprehensive process to align costs globally with its current level of sales and expects an estimated one-time charge of 4.7 million dollars in the fourth quarter. USANA now expects 2025 net sales of about 920 million dollars, diluted earnings per share of about 0.78 dollars, down from a previous range of 1.50 to 2.20 dollars, adjusted earnings per share of about 1.73 dollars and adjusted EBITDA of about 98 million dollars, down from 107 million to 123 million dollars.